Dedicated devices for non-invasive cardiovascular risk assessment - the future of cardiovascular prevention.
作者信息
Rolek Bartosz, Błażejowska Ewelina, Procyk Grzegorz, Zimodro Jakub Michał, Gąsecka Aleksandra
机构信息
1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
出版信息
Cardiol J. 2024;31(3):496-498. doi: 10.5603/cj.96477. Epub 2024 May 20.
Abstract
摘要
相似文献
1
Dedicated devices for non-invasive cardiovascular risk assessment - the future of cardiovascular prevention.
Cardiol J. 2024;31(3):496-498. doi: 10.5603/cj.96477. Epub 2024 May 20.
2
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.
J Am Coll Cardiol. 2023 Feb 21;81(7):633-635. doi: 10.1016/j.jacc.2022.12.007.
3
Improving risk stratification in people with previous manifestations of cardiovascular disease: one size does not fit all in secondary prevention.
Eur J Prev Cardiol. 2024 Jan 25;31(2):216-217. doi: 10.1093/eurjpc/zwad334.
4
Focus on cardiovascular risk factor control.
Eur J Prev Cardiol. 2022 Oct 18;29(13):1715-1717. doi: 10.1093/eurjpc/zwac209.
5
Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
Int J Rheum Dis. 2021 Apr;24(4):473-476. doi: 10.1111/1756-185X.14112.
6
Editor's Presentation: 'Preventive Cardiology: Quo vadis?'.
Eur J Prev Cardiol. 2020 Jan;27(2):115-117. doi: 10.1177/2047487319898968.
7
Is it possible to refine cardiovascular risk scores in people living with HIV?
Eur J Prev Cardiol. 2022 Mar 30;29(4):687-688. doi: 10.1093/eurjpc/zwab225.
8
Redefining Cardiovascular Risk Assessment as a Spectrum: From Binary to Continuous.
J Am Coll Cardiol. 2024 Feb 6;83(5):574-576. doi: 10.1016/j.jacc.2023.11.026.
9
Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond.
Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):48-59. doi: 10.14797/mdcvj.696. eCollection 2021.
10
The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.
Circulation. 2020 Dec 22;142(25):2402-2404. doi: 10.1161/CIRCULATIONAHA.119.040625. Epub 2019 Mar 17.
引用本文的文献
1
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024.
Cardiol J. 2025;32(3):213-227. doi: 10.5603/cj.105140. Epub 2025 May 13.
2
Cardiovascular risks and endothelial dysfunction in reproductive-age women with endometriosis.
Sci Rep. 2024 Oct 15;14(1):24127. doi: 10.1038/s41598-024-73841-7.
3
Leukocyte Extracellular Vesicles Predict Progression of Systolic Dysfunction in Heart Failure with Mildly Reduced Ejection Fraction (LYCHEE) - A Prospective, Multicentre Cohort Study.
J Cardiovasc Transl Res. 2025 Feb;18(1):17-27. doi: 10.1007/s12265-024-10561-3. Epub 2024 Sep 24.
本文引用的文献
1
Non-Invasive Assessment of Vascular Circulation Based on Flow Mediated Skin Fluorescence (FMSF).
Biology (Basel). 2023 Feb 28;12(3):385. doi: 10.3390/biology12030385.
2
Effect of Psychological Stress on Microcirculation Oscillations: Diagnostic Aspects.
Vasc Health Risk Manag. 2023 Feb 10;19:79-82. doi: 10.2147/VHRM.S399082. eCollection 2023.
3
Endothelial Peripheral Arterial Tonometry (Endo-PAT 2000) use in paediatric patients: a systematic review.
BMJ Open. 2023 Jan 18;13(1):e062098. doi: 10.1136/bmjopen-2022-062098.
4
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
BMC Endocr Disord. 2021 Jan 12;21(1):14. doi: 10.1186/s12902-020-00676-4.
5
Changes in Mortality in Top 10 Causes of Death from 2011 to 2018.
J Gen Intern Med. 2021 Aug;36(8):2517-2518. doi: 10.1007/s11606-020-06070-z. Epub 2020 Jul 23.
6
Improving "lab-on-a-chip" techniques using biomedical nanotechnology: a review.
Artif Cells Nanomed Biotechnol. 2016 Nov;44(7):1609-14. doi: 10.3109/21691401.2015.1129619. Epub 2016 Jan 13.
7
Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis.
PLoS One. 2013 Dec 23;8(12):e83084. doi: 10.1371/journal.pone.0083084. eCollection 2013.
8
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function.
Int J Vasc Med. 2012;2012:904141. doi: 10.1155/2012/904141. Epub 2012 Feb 14.
9
Simple non-invasive assessment of advanced glycation endproduct accumulation.
Diabetologia. 2004 Jul;47(7):1324-1330. doi: 10.1007/s00125-004-1451-2. Epub 2004 Jul 9.
Zotero 插件